Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Pavel Butylin"'
Publikováno v:
Cell and Tissue Biology. 12:197-206
In the context of rehabilitation therapy, the proliferation and migration of mesenchymal stem cells (MSCs) are functional properties of which the relationship remains unstudied. The aim of the present work consisted in parallel determination of proli
Publikováno v:
Bulletin of Experimental Biology and Medicine. 164:569-575
We analyzed previously generated stable monocyte-derived cell line carrying mutation JAK2 V617F. Evaluation of the expression of pro- and antifibrotic factors revealed changes in the production of MMPs and their inhibitors, growth factors, galectin-3
Autor:
P. M. Gershovich, NS Belozerova, A.V. Petukhov, EYu Smirnov, AK Titov, Pavel Butylin, Roman Ivanov, A. V. Karabelskii, AYu Zaritskey, Ekaterina Zaikova, Dmitry Motorin, VA Markova
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 11, Iss 1, Pp 1-9 (2018)
Background. The most promising variant of adoptive immunotherapy of the B-line oncohematological diseases includes the use of cells with the chimeric antigen receptor (CAR T-cells), that showed extraordinary results in clinical studies. Aim. To manuf
Autor:
TS Nikulina, Pavel Butylin, EA Stadnik, YuV Virts, TO Andreeva, VV Strugov, AYu Zaritskey, AG Rumyantsev, YuV Mirolyubova
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 11, Iss 2, Pp 167-174 (2018)
Background. In patients with chronic lymphocytic leukemia (CLL) the eradication of minimal residual disease (MRD) is a prognostic factor of overall survival (OS) and progressionfree survival (PFS). IGHV mutational status has also independent prognost
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 10, Iss 1, Pp 75-84 (2017)
Background & Aims. Chronic myeloproliferative disorders typically develop during a long latent period, and it complicates the study of the mechanism of its pathogenesis. Observations from the clinical practice should be confirmed by experiments. The
Autor:
Pavel Butylin, VI Khvan, EG Lisina, NT Siordiya, SN Leleko, OV Sirotkina, AA Silyutina, NM Matyukhina
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 10, Iss 4, Pp 479-484 (2017)
Background. The study of pro- and antifibrotic factors in the serum of patients with Ph-negative chronic myeloproliferative disorders (CMPDs) will allow to understand better the mechanisms of myelofibrosis development, as well as to identify new diag
Autor:
VV Strugov, EA Stadnik, Yu V Mirolyubova, Pavel Butylin, A Yu Zaritskiy, TO Andreeva, Yu V Virts
Publikováno v:
Modern Oncology. 18:33-35
This trial has evaluated a systematic prospective analysis of the efficacy and safety of BR in CLL patients in the routine clinical practice. It included 179 patients with verified CLL diagnosis and the presence of the indications for initiation of t
Autor:
A. V. Strunnikov, Pavel Butylin
Publikováno v:
Cell and Tissue Biology. 2:387-392
Proper chromatin compaction in mitosis (condensation) is required for equal chromosome distribution and the precise inheritance of genetic information. A protein complex called condensin is responsible for mitotic chromosome condensation, chromosome
Publikováno v:
Genes to Cells. 12:1075-1090
The condensin complex is essential for sister chromatid segregation in eukaryotic mitosis. Nevertheless, in budding yeast, condensin mutations result in massive mis-segregation of chromosomes containing the nucleolar organizer, while other chromosome
Autor:
Tatyana Andreeva, Natalya Ilyina, Pavel Butylin, EA Stadnik, Vladimir Strugov, Yulia Mirolubova, Andrey Zaritskey, Yulia Virts
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 16:S46-S47